Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
N Z Med J ; 100(825): 341-2, 1987 Jun 10.
Artigo em Inglês | MEDLINE | ID: mdl-3330584

RESUMO

The susceptibility of urinary tract Escherichia coli isolates to cotrimoxazole, sulphonamide, trimethoprim, and ampicillin was monitored over an 11-year period. A trend in increasing resistance to cotrimoxazole and trimethoprim was observed, but there was no comparable alteration in sulphonamide resistance. Ampicillin resistance was high at the beginning of the survey period and continued to rise.


Assuntos
Resistência a Ampicilina , Anti-Infecciosos Urinários/antagonistas & inibidores , Escherichia coli/efeitos dos fármacos , Sulfametoxazol/antagonistas & inibidores , Sulfonamidas/antagonistas & inibidores , Trimetoprima/antagonistas & inibidores , Sistema Urinário/microbiologia , Combinação de Medicamentos/antagonistas & inibidores , Resistência Microbiana a Medicamentos , Escherichia coli/isolamento & purificação , Humanos , Testes de Sensibilidade Microbiana , Nova Zelândia , Fatores de Tempo , Combinação Trimetoprima e Sulfametoxazol
3.
Orthop Rev ; 16(4): 255-8, 1987 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-3331735

RESUMO

Osteomyelitis is becoming a more common infection. This increase has been associated with an increase in the number of orthopaedic surgical procedures and with severe bone trauma. The etiology of osteomyelitis is also changing, with more gram-negative and more polymicrobial infections due to both gram-positive and gram-negative pathogens. Underlying diseases such as diabetes mellitus, peripheral vascular and sickle cell disease are associated with a poor cure rate when treated with antibiotics. The emergence of resistant strains of bacteria during the long-term treatment necessary for osteomyelitis has been documented, and continues to be a concern, as are the other side effects.


Assuntos
Antibacterianos/uso terapêutico , Osteomielite/tratamento farmacológico , Adulto , Ceftazidima/uso terapêutico , Ácidos Clavulânicos/antagonistas & inibidores , Combinação de Medicamentos/antagonistas & inibidores , Humanos , Infecções Estafilocócicas/tratamento farmacológico , Ticarcilina/antagonistas & inibidores , Inibidores de beta-Lactamases
4.
Clin Neuropharmacol ; 9(6): 542-8, 1986.
Artigo em Inglês | MEDLINE | ID: mdl-3802106

RESUMO

Treatment of migraine with ergot alkaloids may produce systemic vasospasm in patients, especially as a result of automedication and overconsumption but also due to individual hypersensitivity. Peripheral vasoconstriction may lead to gangrene of the extremities, necessitating amputation. Various treatments have been tried against ischemic complications during ergotism with varied and unpredictable results. We report two recent cases of severe acute peripheral ischemia due to ergotamine abuse successfully treated with continuous systemic sodium nitroprusside infusion. The doses used during intraarterial injection are well below those known to be toxic. Consequently, the adverse effects of cyanide toxicity can be avoided. We think that intraarterial infusion of sodium nitroprusside, associated with forced diuresis and the administration of hydroxycobalamin, constitutes the treatment of choice of extreme peripheral ischemia of ergotism.


Assuntos
Ergotismo/tratamento farmacológico , Ferricianetos/uso terapêutico , Nitroprussiato/uso terapêutico , Adulto , Cafeína/efeitos adversos , Cafeína/antagonistas & inibidores , Combinação de Medicamentos/efeitos adversos , Combinação de Medicamentos/antagonistas & inibidores , Ergotamina/efeitos adversos , Ergotamina/antagonistas & inibidores , Feminino , Humanos , Infusões Intra-Arteriais , Nitroprussiato/administração & dosagem
5.
Hum Toxicol ; 5(1): 61-2, 1986 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2936675

RESUMO

Although there is no generally accepted therapy for ergotamine-induced vasoconstriction, infusion of directly acting vasodilators is regarded presently as the treatment of choice. We present a case of peripheral arterial ischaemia secondary to excessive use of ergotamine suppositories, which was reversed with oral thymoxamine hydrochloride (an alpha 1-adrenoceptor antagonist) and ergotamine withdrawal. We suggest that in patients with ergotamine-induced peripheral arterial vasoconstriction with no evidence of gangrene, oral thymoxamine may be considered as a useful adjunct or possible alternative to infused vasodilator treatment.


Assuntos
Cafeína/efeitos adversos , Ergotamina/efeitos adversos , Isquemia/induzido quimicamente , Perna (Membro)/irrigação sanguínea , Moxisilita/uso terapêutico , Adulto , Cafeína/administração & dosagem , Cafeína/antagonistas & inibidores , Combinação de Medicamentos/administração & dosagem , Combinação de Medicamentos/efeitos adversos , Combinação de Medicamentos/antagonistas & inibidores , Ergotamina/administração & dosagem , Ergotamina/antagonistas & inibidores , Feminino , Humanos , Isquemia/tratamento farmacológico , Parestesia/induzido quimicamente , Supositórios
7.
Eur J Clin Microbiol ; 3(5): 424-6, 1984 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-6238821

RESUMO

The practice of using sulfamethoxazole-trimethoprim (SXT) for the selective isolation of Streptococcus pyogenes and as a taxonomic character in the presumptive identification of streptococci was applied to 17 strains of different groups of streptococci to determine their characteristic behaviour in the presence of exogenous thymidine. Streptococcus pyogenes, Streptococcus agalactiae and group D enterococci utilized thymidine, the first two species obtaining a maximum reversal of the inhibitory effect of SXT at thymidine concentrations of 1.2 micrograms/ml and 0.6 micrograms/ml or higher, respectively. For group D enterococci, the degree of reversal of the inhibitory effect was proportional to the thymidine concentration. In contrast, the four viridans species studied (Streptococcus sanguis I, Streptococcus salivarius, Streptococcus mitis and Streptococcus sanguis II) and Streptococcus pneumoniae were unable to utilize thymidine from an exogenous source and thus growth remained inhibited even at the highest concentrations of thymidine tested. For selective isolation and identification of streptococci only stable media with batch-to-batch consistency are recommended together with a known quantity of thymidine.


Assuntos
Antibacterianos/antagonistas & inibidores , Caseínas , Streptococcus/efeitos dos fármacos , Sulfametoxazol/antagonistas & inibidores , Timidina/farmacologia , Trimetoprima/antagonistas & inibidores , Ágar , Antibacterianos/farmacologia , Meios de Cultura , Combinação de Medicamentos/antagonistas & inibidores , Combinação de Medicamentos/farmacologia , Ácido Fólico/metabolismo , Hidrolisados de Proteína , Streptococcus/isolamento & purificação , Streptococcus/metabolismo , Sulfametoxazol/farmacologia , Trimetoprima/farmacologia , Combinação Trimetoprima e Sulfametoxazol
8.
Biull Eksp Biol Med ; 98(8): 206-9, 1984 Aug.
Artigo em Russo | MEDLINE | ID: mdl-6466859

RESUMO

Intracerebroventricular injection of 1-kynurenine sulfate (10 micrograms) eliminated anticaffeine effect of diazepam (5, 10 and 20 mg/kg) in mice. Antipentylenetetrazole (0.5-2.5 mg/kg) and anticonflict (1-2.5 mg/kg) effects of diazepam were not altered by kynurenine (0.1-10 micrograms). The sedative effect of diazepam (1 and 4 mg/kg) was potentiated by kynurenine (1 microgram). Stimulation of locomotion induced by kynurenine (0.5 and 2.5 micrograms) was prevented or perversed by pretreatment with diazepam (1 mg/kg). In a conflict situation test, diazepam and kynurenine had an opposite action, respectively increasing and decreasing the number of transitions between light and dark compartments. The central effects of kynurenine can be related and not related to benzodiazepine receptors.


Assuntos
Diazepam/farmacologia , Cinurenina/farmacologia , Animais , Benzoatos/antagonistas & inibidores , Cafeína/antagonistas & inibidores , Conflito Psicológico , Relação Dose-Resposta a Droga , Combinação de Medicamentos/antagonistas & inibidores , Interações Medicamentosas , Sinergismo Farmacológico , Injeções Intraperitoneais , Injeções Intraventriculares , Camundongos , Camundongos Endogâmicos , Pentilenotetrazol/antagonistas & inibidores , Tempo de Reação/efeitos dos fármacos , Convulsões/induzido quimicamente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...